Search research articles
Contact Us
Filters
Showing results (11-20 of 144) with videos related to
Page
of 15
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
May 17, 2022
Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer: Q&A
William K Oh, Matthew B Rettig
The Nebraska Medical Journal
|
May 1, 1994
Breast cancer screening: recent trends in the use of mammography in Nebraska
B Rettig, N Nelson, R Faulk
Blood
|
September 13, 2003
Transcriptional coactivation of c-Jun by the KSHV-encoded LANA
Jiabin An, Yiping Sun, Matthew B Rettig
Oncogene
|
December 21, 2004
VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-kappaB-dependent mechanism
Jiabin An, Myrna Fisher, Matthew B Rettig
Clinical Advances in Hematology & Oncology : H&O
|
May 17, 2022
Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer
Matthew B Rettig, Himisha Beltran, William K Oh
Journal of Cardiovascular Pharmacology
|
January 1, 1987
Morphologic criteria of progression and regression of cardiac hypertrophy
H Frenzel, B Schwartzkopff, B Rettig, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie
|
September 1, 1996
[Treatment of hyperkinetic children in the home environment]
C Göpel, M H Schmidt, B Blanz, et al.
Molecular Cancer Therapeutics
|
June 24, 2004
Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-kappaB dependent
Jiabin An, Yiping Sun, Myrna Fisher, et al.
Oncogene
|
May 31, 2003
Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways
Jiabin An, Yiping Sun, Ren Sun, et al.
Leukemia
|
September 3, 2004
Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas
J An, Y Sun, M Fisher, et al.
Page
of 15
Search research articles
Search
Showing results (11-20 of 144) with videos related to
Sort By:
Page
of 15
Clinical Advances in Hematology & Oncology : H&O
|
May 17, 2022
Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer: Q&A
William K Oh, Matthew B Rettig
The Nebraska Medical Journal
|
May 1, 1994
Breast cancer screening: recent trends in the use of mammography in Nebraska
B Rettig, N Nelson, R Faulk
Blood
|
September 13, 2003
Transcriptional coactivation of c-Jun by the KSHV-encoded LANA
Jiabin An, Yiping Sun, Matthew B Rettig
Oncogene
|
December 21, 2004
VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-kappaB-dependent mechanism
Jiabin An, Myrna Fisher, Matthew B Rettig
Clinical Advances in Hematology & Oncology : H&O
|
May 17, 2022
Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer
Matthew B Rettig, Himisha Beltran, William K Oh
Journal of Cardiovascular Pharmacology
|
January 1, 1987
Morphologic criteria of progression and regression of cardiac hypertrophy
H Frenzel, B Schwartzkopff, B Rettig, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie
|
September 1, 1996
[Treatment of hyperkinetic children in the home environment]
C Göpel, M H Schmidt, B Blanz, et al.
Molecular Cancer Therapeutics
|
June 24, 2004
Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-kappaB dependent
Jiabin An, Yiping Sun, Myrna Fisher, et al.
Oncogene
|
May 31, 2003
Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways
Jiabin An, Yiping Sun, Ren Sun, et al.
Leukemia
|
September 3, 2004
Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas
J An, Y Sun, M Fisher, et al.
Page
of 15